Skip to search formSkip to main contentSkip to account menu

Celgene

An American biotechnology company that manufactures drug therapies for cancer and inflammatory disorders.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
Review
2019
Review
2019
Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders with a global burden of approximately 6.1 million… 
Review
2018
Review
2018
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
Immune checkpoint inhibitors, as single-agent therapy, have shown modest clinical efficacy in the treatment of acute myeloid… 
Review
2017
Review
2017
Old and New Biological Therapies for Psoriasis
Biological therapy became available for psoriasis with the introduction of alefacept at the beginning of this century. Up to then… 
Review
2016
Review
2016
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
Hidradenitis suppurativa/acne inversa (HS) is a chronic inflammatory skin disease characterized by painful, recurrent nodules and… 
Review
2015
Review
2015
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP…
BackgroundThe Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP), a population-based survey of patients… 
Review
2015
Review
2015
Mantle cell lymphoma: evolving management strategies.
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin's lymphoma that generally affects older individuals and… 
Highly Cited
2015
Highly Cited
2015
A Brief Summary of the Consensus Discussion
  • 2015
  • Corpus ID: 30868726
the international faculty of 22 countries from Europe and the USA but also Asia-Pacific (table 1). The panel openly disclosed any… 
Review
2013
Review
2013
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Review
2012
Review
2012
Overview of safety of non-biologic and biologic DMARDs.
Safety data come from a number of sources. Randomized clinical trials tend to be relatively short, exclude patients with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)